|
|
|
Volumn 105, Issue 21, 2002, Pages
|
|
Sudden death in a patient without heart failure after a single infusion of 200 mg infliximab: does TNF-alpha have protective effects on the failing heart, or does infliximab have direct harmful cardiovascular effects?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
INFLIXIMAB;
MONOCLONAL ANTIBODY;
TUMOR NECROSIS FACTOR ALPHA;
CASE REPORT;
DRUG ANTAGONISM;
DRUG CONTRAINDICATION;
DRUG EFFECT;
ELECTROCARDIOGRAPHY;
HEART;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
MIDDLE AGED;
NOTE;
PHASE 2 CLINICAL TRIAL;
RHEUMATOID ARTHRITIS;
SUDDEN DEATH;
ANTIBODIES, MONOCLONAL;
ARTHRITIS, RHEUMATOID;
CLINICAL TRIALS, PHASE II;
DEATH, SUDDEN;
ELECTROCARDIOGRAPHY;
HEART;
HUMANS;
INFUSIONS, INTRAVENOUS;
MALE;
MIDDLE AGED;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 0037188676
PISSN: 15244539
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (21)
|
|
References (0)
|
